Category: Announcements

CCNA Discoveries Newsletter

Curious to learn about the latest research findings coming out of the Canadian Consortium on Neurodegeneration in Aging (CCNA)? Click on the attached newsletter to read about: Updates on the National Dementia Strategy and how to support CCNA lobbying efforts, The Launch of the Largest Canadian Study on Dementia, COMPASS-ND, New Imaging Techniques that take…

New Funding Opportunities CIHR – Catalyst Grant: Ethics (2016-2017)

Catalyst Grant: Ethics (2016-2017) Application Deadline: 2017-02-28 The purpose of this funding opportunity is to build capacity in ethics as it applies to health (including health research, health promotion, and maintenance, clinical care, population and public health, health systems and services, policy and governance) by encouraging applications from new investigators as well as established investigators…

Dr. Carrie Bourassa named new Scientific Director of CIHR’s Institute of Aboriginal Peoples’ Health

Dr. Alain Beaudet – President of the Canadian Institutes of Health Research (CIHR) – recently announced that Dr. Carrie Bourassa will become the Scientific Director of CIHR’s Institute of Aboriginal Peoples’ Health on February 1, 2017.   Within the Canadian Consortium on Neurodegeneration in Aging (CCNA), Dr. Bourassa co-leads a research team with Dr. Kristen…

This week: CCNA holds 2nd Annual Events (Oct 6-7, 2016 in Vancouver, B.C.)

After Launching Largest Canadian Dementia Study – COMPASS-ND – the Canadian Consortium on Neurodegeneration in Aging (CCNA) holds 2nd Annual Events Dementia has no cure and 25 000 Canadians are diagnosed annually. In an effort to accelerate breakthroughs in dementia services and care, the CCNA holds its annual meeting to share developments in prevention, treatment, and…

Launch of Largest Canadian study on Dementia

To mark World Alzheimer’s Day (September 21, 2016), the Canadian Consortium on Neurodegeneration in Aging (CCNA) is launching its signature clinical study, the Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND). Over the next two years, the study will enroll 1600 participants, between the ages of 50 and 90 with memory problems from 30 sites across…

Q&A at the starting line: The Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND) study

1) What does COMPASS-ND stand for? COMPASS-ND stands for: COMPrehensive ASSessment of Neurodegeneration and Dementia. What this means is we’re looking broadly at different types of dementia (including Alzheimer’s disease, Frontotemporal, Lewy Body, and Parkinson’s related dementia) and even potential pre-dementia conditions, like Mild Cognitive Impairment and Subjective Cognitive Decline. We’re taking this broad approach…